Ultrasound Guided Ureteroscopy and Ureteric Stones
1 other identifier
interventional
80
1 country
1
Brief Summary
The prevalence of urolithiasis is steadily increasing with an estimation of 1 out of 11 people in the United States. The prevalence of calculi in Afro-Asian region including Arab Republic of Egypt ranges from 4% to 20%. Ureteroscopy is one of the first line treatments for definitive management of ureteric stones. Conventional ureteroscopy relies on intraoperative fluoroscopy for visualization and guidance, exposing the patient, surgeon and operating room staff to ionizing radiation. To minimize the hazards of ionizing radiation there has been a trend toward radiation free alternative imaging modalities . Ultrasound provides an excellent alternative for upper urinary tract imaging because it is radiation free, rapid, portable and allows excellent visualization of the renal pelvis and calyces. There is increasing awareness and concern about the clinical use of ionizing radiation and the need to decrease exposure of patients and medical professionals. Ultrasound guided ureteroscopy in pregnant females and children- in whom fluoroscopy is to be minimized or avoided when possible - has been reported.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2018
CompletedFirst Posted
Study publicly available on registry
January 19, 2018
CompletedStudy Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedDecember 5, 2022
December 1, 2022
2 years
January 14, 2018
December 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients treated effectively by the two methods
1 hour
Study Arms (2)
Standardized ureteroscopy group
OTHERUltrasonography ureteroscopy group
OTHERInterventions
The patients will be subjected to rigid ureteroscopy
The patients will be subjected to Ultrasonography
Eligibility Criteria
You may qualify if:
- Patients with single symptomatic lower third ureteric radio-opaque stones indicated for endoscopic treatment.
- Age group 18 years old or above.
- Stone size 15 mm or less.
You may not qualify if:
- Patients with bilateral ureteric stones
- Ureteric congenital anomalies e.g. double ureter and ectopic ureter.
- Previously failed ureteroscopy or previous ureteroneocystostomy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Women Health Hospital - Assiut university
Asyut, 71111, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
January 14, 2018
First Posted
January 19, 2018
Study Start
April 1, 2018
Primary Completion
April 1, 2020
Study Completion
April 1, 2020
Last Updated
December 5, 2022
Record last verified: 2022-12